Junior Group Leader ECR 5: Metabolomics Mass Spectrometry

As part of its strategic planning, the University Medical Center Göttingen (UMG) in the heart of Germany is pursuing the consistent further development of its profile-forming priority research areas Molecular Cell Biology, Neurosciences, Cardiovascular Medicine and Oncology. With its German Centers for Health Research partner (DZHK, DZNE and DZKJ), the excellence cluster “Multiscale Bioimaging”, collaborative research centers, and other collaborative research grants, the UMG offers a dynamic and collaborative research environment.

The decisions on the largest funding initiative in the history of the German state of Lower Saxony have been made: 'Potenziale strategisch entfalten', the joint funding programme of the Lower Saxony Ministry of Science and Culture and the Volkswagen Foundation, will support the universities in Lower Saxony with a total of 265 million euros. The UMG will receive 18.5 million euros of the total funding. This funding enables us to pursue the goals set out in our proposal 'UMG 2032 - Excellence through Focus' in the coming years. Funding is initially available for 5 years.

Over the course of the project, we will focus on bringing together our four established priority research areas and unite them under the cross-organ and cross-disease concept of Metabolic Plasticity. We aim to strengthen collaborative research activities and promote outstanding scientists at all career levels. We also emphasize the deepening of technology transfer to ensure rapid societal application of scientific knowledge. These efforts reflect our commitment to progress and excellence in science.

We are seeking established scientists in an early career phase (up to 6 years post-PhD) who are passionate about advancing Metabolic Plasticity. As an Early Career Researcher leading a Junior Research Group at the UMG, you will have the opportunity to establish a cutting-edge research program with significant impacts. We are particularly interested in candidates who can develop innovative research in areas such as:

• Mitochondrial Homeostasis (ECR 1)
• Inter-Organ Communication (ECR 2)
• Metabolic Neuroimmune Adaptations (ECR 3)
• Transcription and Metabolic Plasticity (ECR 4)
• Metabolomics Mass Spectrometry platform, Advancing Techniques for Studying Metabolic Plasticity (ECR 5)